How skin germs and immune cells work together to keep skin healthy
Skin microbiome regulation of the sebum-immune axis
This research explores how the tiny living organisms on our skin, called the microbiome, interact with our immune system to produce a protective oily substance called sebum.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11112493 on NIH RePORTER |
What this research studies
Our skin has a natural shield against harmful substances and germs, partly thanks to a special oil called sebum. This oil contains substances that fight microbes and helps strengthen the skin's protective barrier. We are looking into a new idea that the skin's microbiome, which are the tiny organisms living on our skin, helps control how our immune system tells the skin to make sebum. This feedback system is important for keeping our skin healthy and creating a good environment for it. Understanding this connection could help us find new ways to support skin health.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients, but future studies stemming from this work may seek individuals with skin conditions related to immune function or the skin microbiome, such as atopic dermatitis.
Not a fit: Patients without skin conditions or those whose conditions are unrelated to the skin microbiome or immune-sebum axis may not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to understand and treat skin conditions like atopic dermatitis by targeting the skin microbiome and immune responses.
How similar studies have performed: This research builds on recent findings that immune cells can regulate sebum production, suggesting a novel and promising area of investigation.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Kambayashi, Taku — University of Pennsylvania
- Study coordinator: Kambayashi, Taku
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.